1. 326 Effects of local laser treatment on vulvovaginal atrophy for women with breast cancer: a prospective study with long-term follow-up. (4th December 2020) Authors: Veron, Lucie; Wehrer, Delphine; Annerose-Zephir, Gisèle; Chaltiel, Dan; Delaloge, Suzette; Pistilli, Barbara; Pautier, Patricia Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age. Issue 4 (April 2021) Authors: Piccart, Martine; van 't Veer, Laura J; Poncet, Coralie; Lopes Cardozo, Josephine M N; Delaloge, Suzette; Pierga, Jean-Yves; Vuylsteke, Peter; Brain, Etienne; Vrijaldenhoven, Suzan; Neijenhuis, Peter A; Causeret, Sylvian; Smilde, Tineke J; Viale, Giuseppe; Glas, Annuska M; Delorenzi, Mauro; Sotir... Journal: Lancet oncology Issue: Volume 22:Issue 4(2021) Page Start: 476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences. Issue 5 (17th July 2013) Authors: Mittempergher, Lorenza; Saghatchian, Mahasti; Wolf, Denise M.; Michiels, Stefan; Canisius, Sander; Dessen, Philippe; Delaloge, Suzette; Lazar, Vladimir; Benz, Stephen C.; Tursz, Thomas; Bernards, René; van't Veer, Laura J. Journal: Molecular oncology Issue: Volume 7:Issue 5(2013:Oct.) Page Start: 987 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A major genetic accelerator of cancer diagnosis: rs867228 in FPR1. (1st January 2021) Authors: Sztupinszki, Zsofia; Le Naour, Julie; Vacchelli, Erika; Laurent-Puig, Pierre; Delaloge, Suzette; Szallasi, Zoltan; Kroemer, Guido Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A response letter to comments on "Contemporary outcomes of metastatic breast cancer among 22, 000 women from the multicentre ESME cohort 2008-2016". (November 2020) Authors: Deluche, Elise; Antoine, Alison; Bachelot, Thomas; Robain, Mathieu; Perol, David; Delaloge, Suzette Journal: European journal of cancer Issue: Volume 140(2020) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A second-generation antibody–drug conjugate to treat HER2-positive breast cancer. Issue 10371 (14th January 2023) Authors: Rassy, Elie; Delaloge, Suzette Journal: Lancet Issue: Volume 401:Issue 10371(2023) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Added Value of Contrast‐Enhanced Spectral Mammography in Postscreening Assessment. Issue 5 (27th June 2016) Authors: Tardivel, Anne‐Marie; Balleyguier, Corinne; Dunant, Ariane; Delaloge, Suzette; Mazouni, Chafika; Mathieu, Marie‐Christine; Dromain, Clarisse Journal: Breast journal Issue: Volume 22:Issue 5(2016:Sep./Oct.) Page Start: 520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial. Issue 1 (January 2020) Authors: Coleman, Robert; Finkelstein, Dianne M; Barrios, Carlos; Martin, Miguel; Iwata, Hiroji; Hegg, Roberto; Glaspy, John; Periañez, Alvaro Montaño; Tonkin, Katia; Deleu, Ines; Sohn, Joohyuk; Crown, John; Delaloge, Suzette; Dai, Tian; Zhou, Ying; Jandial, Danielle; Chan, Arlene Journal: Lancet oncology Issue: Volume 21:Issue 1(2020) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. All simulation models of breast cancer are wrong but some are useful. Issue 8 (August 2018) Authors: Michiels, Stefan; Delaloge, Suzette Journal: Lancet Issue: Volume 6:Issue 8(2018) Page Start: e818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib versus letrozole plus palbociclib for previously untreated ER+/HER2– advanced breast cancer. (March 2022) Authors: Bardia, Aditya; Cortes, Javier; Hurvitz, Sara A.; Delaloge, Suzette; Iwata, Hiroji; Shao, Zhi-Ming; Kanagavel, Dheepak; Cohen, Patrick; Liu, Qianying; Cartot-Cotton, Sylvaine; Pelekanou, Vasiliki; O'Shaughnessy, Joyce Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗